These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10342591)

  • 1. Aplastic anemia responsive to cyclosporine complicating the evolution of polycythemia vera.
    Bouscary D; Jondeau K; Viguié F; Zompi S; Fontenay-Roupie M; Quarre MC; Vassilief D; Dreyfus F; Casadevall N
    Leuk Lymphoma; 1999 May; 33(5-6):607-11. PubMed ID: 10342591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow aplasia after pipobroman: an immune-mediated mechanism?
    Triffet A; Straetmans N; Ferrant A
    Br J Haematol; 2001 Dec; 115(3):713-4. PubMed ID: 11736962
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term incidence of hematological evolution in three French prospective studies of hydroxyurea and pipobroman in polycythemia vera and essential thrombocythemia.
    Kiladjian JJ; Rain JD; Bernard JF; Briere J; Chomienne C; Fenaux P
    Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):417-21. PubMed ID: 16810617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycythemia vera treated with pipobroman as single agent: low incidence of secondary leukemia in a cohort of patients observed during 20 years (1971-1991).
    Petti MC; Spadea A; Avvisati G; Spadea T; Latagliata R; Montefusco E; Cosenza M; Malagnino F
    Leukemia; 1998 Jun; 12(6):869-74. PubMed ID: 9639413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pipobroman therapy of polycythemia vera.
    Najman A; Stachowiak J; Parlier Y; Gorin NC; Duhamel G
    Blood; 1982 May; 59(5):890-4. PubMed ID: 7074217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of polycythemia vera patients treated with pipobroman as initial therapy.
    Kiladjian JJ; Gardin C; Renoux M; Bruno F; Bernard JF
    Hematol J; 2003; 4(3):198-207. PubMed ID: 12764352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Management of polycythaemia with pipobroman].
    Perreau-Boutet MC; Najman A; Stachowiak J; Parlier Y; Gorin NC; Duhamel G
    Nouv Presse Med; 1982 Sep; 11(34):2549-53. PubMed ID: 7133977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute liver disease during treatment with pipobroman and allopurinol].
    Paitel JF; Trechot P; Stockemer V; Dorvaux V; Lederlin P
    Presse Med; 1995 Mar; 24(9):460. PubMed ID: 7746823
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of polycythemia vera and essential thrombocythemia: the role of pipobroman.
    Passamonti F; Lazzarino M
    Leuk Lymphoma; 2003 Sep; 44(9):1483-8. PubMed ID: 14565648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of polycythemia vera with hydroxyurea or pipobroman. Efficacy and toxicity analysed from a protocol of 96 patients under 65 years of age. Le Groupe d'Etude des Polyglobulies].
    Najean Y
    Presse Med; 1992 Nov; 21(37):1753-7. PubMed ID: 1488420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indications, procedure and results for the treatment of polycythaemia vera by bleeding, pipobroman and hydroxyurea.
    Boivin P
    Nouv Rev Fr Hematol (1978); 1993; 35(5):491-8. PubMed ID: 8295823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of pipobroman in the treatment of polycythemia vera: long-term results in 163 patients.
    Passamonti F; Brusamolino E; Lazzarino M; Baraté C; Klersy C; Orlandi E; Canevari A; Castelli G; Merante S; Bernasconi C
    Haematologica; 2000 Oct; 85(10):1011-8. PubMed ID: 11025590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of polycythemia. II.--Comparison of hydroxyurea with pipobroman in 294 patients less than 65 years of age].
    Najean Y; Rain JD; Lejeune F; Echard M; Fermand JP; Gruyer P; Brahimi S
    Ann Med Interne (Paris); 1998 Mar; 149(2):94-100. PubMed ID: 11490531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of polycythemia vera with hydroxyurea and pipobroman: final results of a randomized trial initiated in 1980.
    Kiladjian JJ; Chevret S; Dosquet C; Chomienne C; Rain JD
    J Clin Oncol; 2011 Oct; 29(29):3907-13. PubMed ID: 21911721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical trial of pipobroman (N,N'-bis-(3-bromopropionyl) piperazine) in eight patients with polycythemia vera].
    Miyazaki T; Ishizaki T; Maekawa I; Sano H; Idaka K
    Rinsho Ketsueki; 1972 Oct; 13(5):777-86. PubMed ID: 4674853
    [No Abstract]   [Full Text] [Related]  

  • 16. Antithymocyte globulin and cyclosporine in children with aplastic anemia: a developing country experience.
    Sharma R; Chandra J; Sharma S; Pemde H; Singh V
    J Pediatr Hematol Oncol; 2012 Mar; 34(2):93-5. PubMed ID: 22278201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemic transformation in polycythemia Vera. MPD(UK) Study Group.
    Pearson TC; Green AR; Reilly JT; Harrisoni G
    Blood; 1998 Sep; 92(5):1837-8. PubMed ID: 9716616
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pipobroman in the treatment of some cases of polycythemia vera].
    Bignotti G; Visca U; Confalonieri C
    Haematologica; 1971; 56(3):157-62. PubMed ID: 5003588
    [No Abstract]   [Full Text] [Related]  

  • 19. Is hydroxyurea leukemogenic in essential thrombocythemia?
    Tefferi A
    Blood; 1998 Aug; 92(4):1459-60; author reply 1460-1. PubMed ID: 9694740
    [No Abstract]   [Full Text] [Related]  

  • 20. A case of factitious aplastic anemia.
    Bright R; Eisendrath S; Damon L
    Int J Psychiatry Med; 2001; 31(4):433-41. PubMed ID: 11949741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.